Cas no 544-64-9 (Myristoleic acid)
Myristoleic acid Chemical and Physical Properties
Names and Identifiers
-
- 9-Tetradecenoic acid,(9Z)-
- 9-cis-Tetradecenoic acid
- MYRISTOLEIC ACID
- 9-cis-Tetradecenoic acid1000μg
- cis-9-tetradecenoic acid
- tetradecenoic acid
- Z-9-octadecene-4-olide
- Z-9-tetradecenoic acid
- (9Z)-9-Tetradecenoic acid
- (Z)-9-Tetradecenoic acid
- 9(Z)-Tetradecenoic acid
- Myristoleic acid
-
- Inchi: 1S/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h5-6H,2-4,7-13H2,1H3,(H,15,16)/b6-5-
- InChI Key: YWWVWXASSLXJHU-WAYWQWQTSA-N
- SMILES: OC(CCCCCCC/C=C\CCCC)=O
Computed Properties
- Exact Mass: 226.19300
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 16
- Rotatable Bond Count: 11
- Complexity: 185
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- XLogP3: 5.1
- Topological Polar Surface Area: 37.3
Experimental Properties
- Color/Form: Not determined
- Density: 0.9?g/mL?at 25?°C(lit.)
- Melting Point: ?4.5-?4?°C (lit.)
- Boiling Point: 144?°C/0.6?mmHg(lit.)
- Flash Point: Fahrenheit: 143.6 ° f
Celsius: 62 ° c - Refractive Index: n20/D 1.4562(lit.)
- Solubility: Almost insoluble (0.041 g/l) (25 o C),
- PSA: 37.30000
- LogP: 4.54810
- Solubility: Not determined
Myristoleic acid Security Information
-
Symbol:
- Signal Word:Warning
- Hazard Statement: H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Hazardous Material transportation number:UN 1993 / PGIII
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: S26; S36
-
Hazardous Material Identification:
- Risk Phrases:R36/37/38
- Storage Condition:?20°C
Myristoleic acid Customs Data
- HS CODE:2916190090
- Customs Data:
China Customs Code:
2916190090Overview:
2916190090 Other unsaturated acyclic monocarboxylic acids(Including its anhydride\Acyl halide,Peroxides and peroxyacids and their derivatives).Regulatory conditions:AB(Customs clearance form for Inbound Goods,Customs clearance form for outbound goods).VAT:17.0%.Tax refund rate:9.0%.MFN tariff:6.5%.general tariff:30.0%
Declaration elements:
Product Name, component content, use to, Acrylic acid\Acrylates or esters shall be packaged clearly
Regulatory conditions:
A.Customs clearance form for Inbound Goods
B.Customs clearance form for outbound goodsInspection and quarantine category:
R.Sanitary supervision and inspection of imported food
S.Sanitary supervision and inspection of exported food
M.Import commodity inspection
N.Export commodity inspectionSummary:
2916190090 unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives.supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward).VAT:17.0%.tax rebate rate:9.0%.MFN tariff:6.5%.general tariff:30.0%
Myristoleic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI YUAN YE Biotechnology Co., Ltd. | S25232-100mg |
Myristoleic Acid |
544-64-9 | ≥98%(GC) | 100mg |
¥1400.00 | 2021-09-02 | |
| SHANG HAI YUAN YE Biotechnology Co., Ltd. | S25232-1g |
Myristoleic Acid |
544-64-9 | ≥98%(GC) | 1g |
¥8000.00 | 2021-09-02 | |
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | M3525-100MG |
Myristoleic acid |
544-64-9 | 100mg |
¥2079.12 | 2023-09-30 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | M3525-1G |
Myristoleic acid |
544-64-9 | 1g |
¥8461.56 | 2023-09-30 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 41788-100MG |
Myristoleic acid |
544-64-9 | 100mg |
¥4545.62 | 2023-10-24 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | M912485-50mg |
Myristoleic Acid |
544-64-9 | 98% | 50mg |
¥3,788.00 | 2022-01-13 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | M76060-100mg |
Myristoleic Acid |
544-64-9 | 100mg |
¥2502.0 | 2021-09-08 | ||
| Larodan | 10-1401-30-5x100mg |
9(Z)-Tetradecanoic acid |
544-64-9 | >99% | 5x100mg |
€437.00 | 2025-03-07 | |
| Larodan | 10-1401-9-100mg |
9(Z)-Tetradecanoic acid |
544-64-9 | >99% | 100mg |
€143.00 | 2025-03-07 | |
| MedChemExpress | HY-113332-50mg |
Myristoleic acid |
544-64-9 | ≥98.0% | 50mg |
¥4000 | 2022-06-06 |
Myristoleic acid Suppliers
Myristoleic acid Related Literature
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
Related Categories
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Long-chain fatty acids
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Long-chain fatty acids
- Natural Products and Extracts Plant Extracts Plant based Erucaria microcarpa
Additional information on Myristoleic acid
Introduction to Myristoleic Acid (CAS No. 544-64-9): Applications and Recent Research Findings
Myristoleic acid, with the chemical formula C14H26O2, is a naturally occurring monounsaturated fatty acid that has garnered significant attention in the field of pharmaceuticals and biochemistry due to its unique structural properties and biological activities. Its CAS number, 544-64-9, provides a standardized identifier for this compound, facilitating its recognition and study in scientific literature. Myristoleic acid is characterized by a double bond between the 9th and 10th carbon atoms, making it a member of the omega-9 family of fatty acids. This distinct molecular configuration contributes to its distinct physicochemical properties and biological functions, which have been extensively explored in recent years.
The importance of Myristoleic acid stems from its multifaceted roles in cellular processes, including membrane fluidity, signal transduction, and anti-inflammatory responses. Its presence has been identified in various tissues and organisms, suggesting a broad biological significance. Recent studies have highlighted its potential in modulating immune responses and reducing oxidative stress, making it a promising candidate for therapeutic applications.
In the realm of pharmaceutical research, Myristoleic acid has been investigated for its potential anti-inflammatory and analgesic properties. Studies have demonstrated that it can interact with various cellular receptors and enzymes, thereby influencing pathways involved in inflammation and pain perception. For instance, research published in peer-reviewed journals has shown that Myristoleic acid can inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, which are key mediators of inflammatory processes. These findings have opened new avenues for developing novel therapeutic strategies targeting chronic inflammatory diseases.
The structural uniqueness of Myristoleic acid also makes it an attractive candidate for drug development. Its ability to incorporate into cell membranes without significantly altering their fluidity has led to investigations into its role as a membrane-targeting agent. Preliminary studies suggest that it may enhance the delivery of other bioactive molecules across cell membranes, potentially improving the efficacy of drug formulations. This property could be particularly beneficial in developing treatments for conditions where membrane permeability is a limiting factor.
Another area of interest is the potential of Myristoleic acid as an antioxidant compound. Oxidative stress is implicated in various pathological conditions, including neurodegenerative diseases, cardiovascular disorders, and cancer. Research has indicated that Myristoleic acid can scavenge free radicals and reduce lipid peroxidation, thereby protecting cells from oxidative damage. A study published in the Journal of Lipid Research demonstrated that dietary supplementation with Myristoleic acid could attenuate oxidative stress-induced neuronal damage in experimental models. These findings suggest that Myristoleic acid may have neuroprotective effects, which could be exploited in developing therapies for neurological disorders.
The role of Myristoleic acid in metabolic health has also been explored recently. Emerging evidence suggests that it may play a role in regulating lipid metabolism and insulin sensitivity. Studies have shown that Myristoleic acid can modulate the activity of enzymes involved in fatty acid synthesis and oxidation, potentially contributing to improved metabolic function. Furthermore, its ability to enhance insulin sensitivity may make it a valuable component in managing type 2 diabetes.
Beyond its therapeutic potential, Myristoleic acid has been studied for its cosmetic applications due to its moisturizing and anti-inflammatory properties. Its incorporation into skincare formulations has been shown to improve skin hydration and reduce redness associated with inflammatory conditions such as eczema. This dual functionality as both a therapeutic agent and a cosmetic ingredient underscores the versatility of Myristoleic acid.
The biosynthesis of Myristoleic acid is another area of active research. Understanding the pathways through which this compound is produced can provide insights into how it regulates various physiological processes. Recent studies have identified key enzymes involved in the biosynthesis of Myristoleic acid, shedding light on the molecular mechanisms underlying its production. This knowledge could be leveraged to develop strategies for enhancing endogenous levels of Myristoleic acid or for synthesizing analogs with improved biological activities.
The future prospects for Myристолеинная кислота (CAS No. 544-64-9) are promising, with ongoing research aimed at elucidating its mechanisms of action and exploring new therapeutic applications. Advances in metabolomics and lipidomics are expected to provide deeper insights into how Myristoleic acid interacts with biological systems at a molecular level. Additionally, clinical trials are underway to evaluate its efficacy in treating various diseases.
In conclusion,Myристолеинная кислота (CAS No. 544-64-9) stands out as a compound with significant potential across multiple domains of health and medicine due to its unique chemical structure and diverse biological activities. The latest research highlights its roles as an anti-inflammatory agent、antioxidant、and metabolic regulator,making it an exciting area for future exploration。As scientific understanding continues to evolve,the applications for this remarkable fatty acid are likely to expand,offering new hope for innovative treatments。
544-64-9 (Myristoleic acid) Related Products
- 63958-55-4(5-Tetradecenoic acid, 14-hydroxy-, (Z)-)
- 64275-71-4(5,10-Pentadecadienoic acid, (Z,E)-)
- 64275-70-3(5,10-Pentadecadienoic acid, (E,Z)-)
- 68311-06-8((9Z)-octadec-9-enoic acid - octadecanoic acid (1:1))
- 68412-07-7(9-Octadecenoic acid (Z)-, sulfurized)
- 64275-68-9(5,10-Pentadecadienoic acid, (E,E)-)
- 67701-11-5(Fatty acids, C14-18 and C16-18-unsatd., sodium salts)
- 64252-91-1(4-Pentadecenoic acid, (4Z)-)
- 64275-69-0(5,10-Pentadecadienoic acid, (Z,Z)-)
- 68351-48-4(13-Tetracosenoic acid, (13Z)-)